| scholarly article | Q13442814 |
| P50 | author | Menachem Miodovnik | Q110265740 |
| Sara Eyal | Q38803455 | ||
| P2093 | author name string | Jason G Umans | |
| Thomas R Easterling | |||
| Mary F Hebert | |||
| Rachel J Ryu | |||
| Henry G Kaplan | |||
| Kathleen A Scorsone | |||
| Stacey L Berg | |||
| Arezoo Akbarzadeh | |||
| Eric M Feldman | |||
| Karen Hays | |||
| Kristin Puhl | |||
| P2860 | cites work | Pharmacokinetics of the cardioprotector ADR-529 (ICRF-187) in escalating doses combined with fixed-dose doxorubicin | Q28317288 |
| Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity | Q29614981 | ||
| Factors affecting pharmacokinetic variability following doxorubicin and docetaxel-based therapy. | Q34547428 | ||
| Use of chemotherapy during human pregnancy | Q35761685 | ||
| Carbonyl reductases: the complex relationships of mammalian carbonyl- and quinone-reducing enzymes and their role in physiology | Q36607363 | ||
| Estradiol-17beta, prostaglandin E2 (PGE2), and the PGE2 receptor are involved in PGE2 positive feedback loop in the porcine endometrium | Q37272680 | ||
| Chemotherapy in non-Hodgkin's lymphoma during pregnancy | Q37716266 | ||
| Adriamycin metabolism in man. Evidence from urinary metabolites | Q39082453 | ||
| Clinical pharmacokinetics of doxorubicin | Q39513605 | ||
| Management of cancer during pregnancy | Q39520967 | ||
| Renal hemodynamics and tubular function normal human pregnancy | Q40295235 | ||
| Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion | Q42263291 | ||
| Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study | Q42905794 | ||
| Protection from doxorubicin-induced cardiac toxicity in mice with a null allele of carbonyl reductase 1 | Q44635445 | ||
| Bilary disposition of adriamycin | Q44912291 | ||
| Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum | Q45188816 | ||
| Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver | Q46477452 | ||
| Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study | Q46743429 | ||
| Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction | Q46791680 | ||
| Breast cancer during pregnancy: maternal and fetal outcomes | Q47563843 | ||
| Chemotherapy during pregnancy and its effects on the fetus--neonatal myelosuppression: two case reports. | Q51082718 | ||
| Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols. | Q52433291 | ||
| Assessment of the hepatic arterial and portal venous blood flows during pregnancy with Doppler ultrasonography. | Q52939423 | ||
| Total body water in pregnancy: assessment by using bioelectrical impedance. | Q54212779 | ||
| Pharmacokinetics of doxorubicin in sarcoma patients | Q59359012 | ||
| Doxorubicin clearance in the obese | Q68489640 | ||
| Doxorubicin and doxorubicinol: intra- and inter-individual variations of pharmacokinetic parameters | Q68640932 | ||
| Changes and localization of ovarian carbonyl reductase during pseudopregnancy and pregnancy in rats | Q68649310 | ||
| Pharmacokinetics and metabolism of adriamycin in man | Q69559062 | ||
| Cancer and pregnancy | Q70436960 | ||
| Interactions between cyclophosphamide and adriamycin metabolism in rats | Q70471806 | ||
| Protein binding of anthraquinone glycosides, with special reference to adriamycin | Q70561502 | ||
| Comparative serum protein binding of anthracycline derivatives | Q71572398 | ||
| Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry | Q71730035 | ||
| Doxorubicin in pregnancy: possible transplacental passage | Q71821522 | ||
| Transplacental passage of doxorubicin | Q72542034 | ||
| Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small cell lung cancer | Q72970794 | ||
| Effect of pregnancy on the pharmacokinetics of paclitaxel: a case report | Q79339662 | ||
| Impact of body composition on pharmacokinetics of doxorubicin in children: a Glaser Pediatric Research Network study | Q82669491 | ||
| Doxorubicin in lymphoma: association between pharmacokinetic variability and clinical response | Q84933591 | ||
| P433 | issue | 4 | |
| P921 | main subject | human pregnancy | Q11995 |
| doxorubicin | Q18936 | ||
| pharmacokinetics | Q323936 | ||
| pregnant person | Q104720811 | ||
| P304 | page(s) | 789-797 | |
| P577 | publication date | 2014-02-15 | |
| P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
| P1476 | title | Pharmacokinetics of doxorubicin in pregnant women | |
| P478 | volume | 73 |
| Q39012759 | Age-Dependent Pharmacokinetics of Doxorubicin in Children with Cancer. |
| Q38256590 | Basic obstetric pharmacology |
| Q90899172 | Codelivery of Adriamycin and P-gp Inhibitor Quercetin Using PEGylated Liposomes to Overcome Cancer Drug Resistance |
| Q47164600 | Does anthracycline-based chemotherapy in pregnant women with cancer offer safe cardiac and neurodevelopmental outcomes for the developing fetus? |
| Q36912561 | Doxorubicin induced heart failure: Phenotype and molecular mechanisms. |
| Q92048382 | Maternal ABVD chemotherapy for Hodgkin lymphoma in a dichorionic diamniotic pregnancy: a case report |
| Q50117850 | Pharmacokinetics of dacarbazine (DTIC) in pregnancy |
| Q46770269 | Phase I and pharmacokinetic study of the novel anthracycline derivative 5-imino-13-deoxydoxorubicin (GPX-150) in patients with advanced solid tumors |
| Q39570922 | Population pharmacokinetics of doxorubicin and doxorubicinol in patients diagnosed with non-Hodgkin's lymphoma |
| Q28109657 | Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review |
| Q38809225 | Pregnancy-related pharmacokinetic changes |
Search more.